Table of Content

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Porter’s Five Forces

5.1 Bargaining Power of Buyer
5.2 Bargaining Power of Supplier
5.3 Threat of New Entrants
5.4 Rivalry among Existing Competitors
5.5 Threat of Substitute Products


6. SWOT Analysis

6.1 Strengths
6.2 Weaknesses
6.3 Opportunities
6.4 Threats


7. France In-Vitro Diagnostics (IVD) Market


8. Market Share – France In-Vitro Diagnostics (IVD)

8.1 By Test Types
8.2 By Technology
8.3 By Products Types
8.4 By Application
8.5 By End User


9. Test Types – France In-Vitro Diagnostics (IVD) Market

9.1 ELISA & CLIA
9.2 PCR
9.3 Rapid Test
9.4 Fluorescence Immunoassays (FIA)
9.5 In Situ Hybridization
9.6 Transcription Mediated Amplification
9.7 Sequencing
9.8 Colorimetric Immunoassay
9.9 Radioimmunoassay (RIA)
9.10 Isothermal Nucleic Acid Amplification Technology
9.11 Others


10. Technology – France In-Vitro Diagnostics (IVD) Market

10.1 Immunoassay
10.2 Clinical Chemistry
10.3 Molecular Diagnostics/Genetics
10.4 Hematology
10.5 Microbiology
10.6 Coagulation
10.7 Others


11. Product Types – France In-Vitro Diagnostics (IVD) Market

11.1 Services
11.2 Instruments
11.3 Reagents


12. Application – France In-Vitro Diagnostics (IVD) Market

12.1 Infectious Disease
12.2 Diabetes
12.3 Cardiology
12.4 Oncology
12.5 Nephrology
12.6 Autoimmune Diseases
12.7 Drug Testing
12.8 Other Applications


13. End User – France In-Vitro Diagnostics (IVD) Market

13.1 Hospitals
13.2 Laboratories
13.3 Home - Care
13.4 Others


14. Government Rules & Regulation


15. Reimbursement

15.1 Public
15.2 Private & Insurance


16. Company Analysis

16.1 Roche Diagnostics

16.1.1 Overview
16.1.2 Resent Development
16.1.3 Revenue

16.2 Abbott Diagnostics

16.2.1 Overview
16.2.2 Resent Development
16.2.3 Revenue

16.3 Siemens Healthineers

16.3.1 Overview
16.3.2 Resent Development
16.3.3 Revenue

16.4 Danaher Corporation

16.4.1 Overview
16.4.2 Resent Development
16.4.3 Revenue

16.5 Thermo Fisher Scientific

16.5.1 Overview
16.5.2 Resent Development
16.5.3 Revenue

16.6 Sysmex Corporation

16.6.1 Overview
16.6.2 Resent Development
16.6.3 Revenue

16.7 QIAGEN N.V.

16.7.1 Overview
16.7.2 Resent Development
16.7.3 Revenue



List of Figures

Figure-01: France – In-Vitro Diagnostics Market (Billion US$), 2018 – 2022
Figure-02: France – Forecast for In-Vitro Diagnostics Market (Billion US$), 2023 – 2028
Figure-03: Test Types – ELISA & CLIA Market (Million US$), 2018 – 2022
Figure-04: Test Types – Forecast for ELISA & CLIA Market (Million US$), 2023 – 2028
Figure-05: Test Types – PCR Market (Million US$), 2018 – 2022
Figure-06: Test Types – Forecast for PCR Market (Million US$), 2023 – 2028
Figure-07: Test Types – Rapid Test Market (Million US$), 2018 – 2022
Figure-08: Test Types – Forecast for Rapid Test Market (Million US$), 2023 – 2028
Figure-09: Test Types – Fluorescence Immunoassays (FIA) Market (Million US$), 2018 – 2022
Figure-10: Test Types – Forecast for Fluorescence Immunoassays (FIA) Market (Million US$), 2023 – 2028
Figure-11: Test Types – In Situ Hybridization Market (Million US$), 2018 – 2022
Figure-12: Test Types – Forecast for In Situ Hybridization Market (Million US$), 2023 – 2028
Figure-13: Test Types – Transcription Mediated Amplification Market (Million US$), 2018 – 2022
Figure-14: Test Types – Forecast for Transcription Mediated Amplification Market (Million US$), 2023 – 2028
Figure-15: Test Types – Sequencing Market (Million US$), 2018 – 2022
Figure-16: Test Types – Forecast for Sequencing Market (Million US$), 2023 – 2028
Figure-17: Test Types – Colorimetric Immunoassay Market (Million US$), 2018 – 2022
Figure-18: Test Types – Forecast for Colorimetric Immunoassay Market (Million US$), 2023 – 2028
Figure-19: Test Types – Radioimmunoassay (RIA) Market (Million US$), 2018 – 2022
Figure-20: Test Types – Forecast for Radioimmunoassay (RIA) Market (Million US$), 2023 – 2028
Figure-21: Test Types – Isothermal Nucleic Acid Amplification Technology Market (Million US$), 2018 – 2022
Figure-22: Test Types – Forecast for Isothermal Nucleic Acid Amplification Technology Market (Million US$), 2023 – 2028
Figure-23: Test Types – Others Market (Million US$), 2018 – 2022
Figure-24: Test Types – Forecast for Others Market (Million US$), 2023 – 2028
Figure-25: Technology – Immunoassay Market (Million US$), 2018 – 2022
Figure-26: Technology – Forecast for Immunoassay Market (Million US$), 2023 – 2028
Figure-27: Technology – Clinical Chemistry Market (Million US$), 2018 – 2022
Figure-28: Technology – Forecast for Clinical Chemistry Market (Million US$), 2023 – 2028
Figure-29: Technology – Molecular Diagnostics/Genetics Market (Million US$), 2018 – 2022
Figure-30: Technology – Forecast for Molecular Diagnostics/Genetics Market (Million US$), 2023 – 2028
Figure-31: Technology – Hematology Market (Million US$), 2018 – 2022
Figure-32: Technology – Forecast for Hematology Market (Million US$), 2023 – 2028
Figure-33: Technology – Microbiology Market (Million US$), 2018 – 2022
Figure-34: Technology – Forecast for Microbiology Market (Million US$), 2023 – 2028
Figure-35: Technology – Coagulation Market (Million US$), 2018 – 2022
Figure-36: Technology – Forecast for Coagulation Market (Million US$), 2023 – 2028
Figure-37: Technology – Others Market (Million US$), 2018 – 2022
Figure-38: Technology – Forecast for Others Market (Million US$), 2023 – 2028
Figure-39: Product Types – Services Market (Million US$), 2018 – 2022
Figure-40: Product Types – Forecast for Services Market (Million US$), 2023 – 2028
Figure-41: Product Types – Instruments Market (Million US$), 2018 – 2022
Figure-42: Product Types – Forecast for Instruments Market (Million US$), 2023 – 2028
Figure-43: Product Types – Reagents Market (Million US$), 2018 – 2022
Figure-44: Product Types – Forecast for Reagents Market (Million US$), 2023 – 2028
Figure-45: Product Types – Infectious Disease Market (Million US$), 2018 – 2022
Figure-46: Product Types – Forecast for Infectious Disease Market (Million US$), 2023 – 2028
Figure-47: Application – Diabetes Market (Million US$), 2018 – 2022
Figure-48: Application – Forecast for Diabetes Market (Million US$), 2023 – 2028
Figure-49: Application – Cardiology Market (Million US$), 2018 – 2022
Figure-50: Application – Forecast for Cardiology Market (Million US$), 2023 – 2028
Figure-51: Application – Oncology Market (Million US$), 2018 – 2022
Figure-52: Application – Forecast for Oncology Market (Million US$), 2023 – 2028
Figure-53: Application – Nephrology Market (Million US$), 2018 – 2022
Figure-54: Application – Forecast for Nephrology Market (Million US$), 2023 – 2028
Figure-55: Application – Autoimmune Diseases Market (Million US$), 2018 – 2022
Figure-56: Application – Forecast for Autoimmune Diseases Market (Million US$), 2023 – 2028
Figure-57: Application – Drug Testing Market (Million US$), 2018 – 2022
Figure-58: Application – Forecast for Drug Testing Market (Million US$), 2023 – 2028
Figure-59: Application – Other Applications Market (Million US$), 2018 – 2022
Figure-60: Application – Forecast for Other Applications Market (Million US$), 2023 – 2028
Figure-61: End User – Hospitals Market (Million US$), 2018 – 2022
Figure-62: End User – Forecast for Hospitals Market (Million US$), 2023 – 2028
Figure-63: End User – Laboratories Market (Million US$), 2018 – 2022
Figure-64: End User – Forecast for Laboratories Market (Million US$), 2023 – 2028
Figure-65: End User – Home - Care Market (Million US$), 2018 – 2022
Figure-66: End User – Forecast for Home - Care Market (Million US$), 2023 – 2028
Figure-67: End User – Others Market (Million US$), 2018 – 2022
Figure-68: End User – Forecast for Others Market (Million US$), 2023 – 2028
Figure-69: Roche Diagnostics – Global Revenue (Billion US$), 2018 – 2022
Figure-70: Roche Diagnostics – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-71: Abbott Diagnostics – Global Revenue (Billion US$), 2018 – 2022
Figure-72: Abbott Diagnostics – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-73: Siemens Healthineers – Global Revenue (Billion US$), 2018 – 2022
Figure-74: Siemens Healthineers – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-75: Danaher Corporation – Global Revenue (Billion US$), 2018 – 2022
Figure-76: Danaher Corporation – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-77: Thermo Fisher Scientific – Global Revenue (Billion US$), 2018 – 2022
Figure-78: Thermo Fisher Scientific – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-79: Sysmex Corporation – Global Revenue (Million US$), 2018 – 2022
Figure-80: Sysmex Corporation – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-81: QIAGEN N.V. – Global Revenue (Million US$), 2018 – 2022
Figure-82: QIAGEN N.V. – Forecast for Global Revenue (Million US$), 2023 – 2028

List of Tables

Table-01: France – In-Vitro Diagnostics Market Share by Test Types (Percent), 2018 – 2022
Table-02: France – Forecast for In-Vitro Diagnostics Market Share by Test Types (Percent), 2023 – 2028
Table-03: France – In-Vitro Diagnostics Market Share by Technology (Percent), 2018 – 2022
Table-04: France – Forecast for In-Vitro Diagnostics Market Share by Technology (Percent), 2023 – 2028
Table-05: France – In-Vitro Diagnostics Market Share by Products (Percent), 2018 – 2022
Table-06: France – Forecast for In-Vitro Diagnostics Market Share by Products (Percent), 2023 – 2028
Table-07: France – In-Vitro Diagnostics Market Share by Application (Percent), 2018 – 2022
Table-08: France – Forecast for In-Vitro Diagnostics Market Share by Application (Percent), 2023 – 2028
Table-09: France – In-Vitro Diagnostics Market Share by End User (Percent), 2018 – 2022
Table-10: France – Forecast for In-Vitro Diagnostics Market Share by End User (Percent), 2023 – 2028